EP4008309A4 - BRUCIN GEL FORMULATION AND PROCESS OF PRODUCTION - Google Patents
BRUCIN GEL FORMULATION AND PROCESS OF PRODUCTION Download PDFInfo
- Publication number
- EP4008309A4 EP4008309A4 EP20850549.5A EP20850549A EP4008309A4 EP 4008309 A4 EP4008309 A4 EP 4008309A4 EP 20850549 A EP20850549 A EP 20850549A EP 4008309 A4 EP4008309 A4 EP 4008309A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- brucin
- production
- gel formulation
- formulation
- gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910709653.XA CN112386565B (en) | 2019-08-02 | 2019-08-02 | Strychnine gel preparation and preparation method thereof |
| PCT/CN2020/106108 WO2021023099A1 (en) | 2019-08-02 | 2020-07-31 | Brucine gel formulation and preparation method therefor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP4008309A1 EP4008309A1 (en) | 2022-06-08 |
| EP4008309A4 true EP4008309A4 (en) | 2023-08-23 |
Family
ID=74503248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP20850549.5A Pending EP4008309A4 (en) | 2019-08-02 | 2020-07-31 | BRUCIN GEL FORMULATION AND PROCESS OF PRODUCTION |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220313683A1 (en) |
| EP (1) | EP4008309A4 (en) |
| JP (1) | JP2022542304A (en) |
| KR (1) | KR20220042147A (en) |
| CN (1) | CN112386565B (en) |
| WO (1) | WO2021023099A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023551417A (en) * | 2020-11-20 | 2023-12-08 | セーリング ファーマシューティカル テクノロジー グループ カンパニー リミテッド | Brusingel plaster, its manufacturing method and use |
| CN114931548A (en) * | 2022-05-19 | 2022-08-23 | 季华实验室 | Preparation method of gendarussa wine gel paste |
| CN115896237A (en) * | 2022-12-19 | 2023-04-04 | 许奕鹏 | Gel reagent, kit and rapid screening method for rapid screening of urease activity |
| CN115919754B (en) * | 2023-01-06 | 2023-09-12 | 广州家安化妆品有限公司 | Mucosal sterilizing gel for inactivating viruses and preparation method thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5747021A (en) * | 1997-01-10 | 1998-05-05 | Mckenzie; Therman | After shave treatment composition |
| US20100029765A1 (en) * | 2008-07-30 | 2010-02-04 | Ranbaxy Labortories Limited | Topical aqueous composition comprising tretinoin |
| CN102008476B (en) * | 2010-11-22 | 2015-01-07 | 南京中医药大学 | Hydroxypropyl-beta-cyclodextrin inclusion of strychnine and preparation method thereof |
| HRP20201731T1 (en) * | 2011-01-07 | 2020-12-25 | Anji Pharma (Us) Llc | CHEMOSENSORIC RECEPTOR LIGAND-BASED THERAPIES |
| KR20230129619A (en) * | 2013-08-21 | 2023-09-08 | 베리카 파마슈티컬스 인크. | Compositions, methods and systems for the treatment of cutaneous disorders |
| NZ738815A (en) * | 2015-07-13 | 2019-10-25 | Dr Reddy’s Laboratories Ltd | Topical retinoid compositions |
-
2019
- 2019-08-02 CN CN201910709653.XA patent/CN112386565B/en active Active
-
2020
- 2020-07-31 JP JP2022506060A patent/JP2022542304A/en active Pending
- 2020-07-31 KR KR1020227004705A patent/KR20220042147A/en not_active Withdrawn
- 2020-07-31 US US17/630,680 patent/US20220313683A1/en active Pending
- 2020-07-31 EP EP20850549.5A patent/EP4008309A4/en active Pending
- 2020-07-31 WO PCT/CN2020/106108 patent/WO2021023099A1/en not_active Ceased
Non-Patent Citations (5)
| Title |
|---|
| "Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement: Modification of the Stratum Corneum", 3 November 2015, SPRINGER, article DRAGICEVIC NINA ET AL: "Part 2 Chemical Penetration Enhancers in Penetration Enhancement; 2 Chemical Penetration Enhancers: Classification and Mode of Action", pages: 20 - 21, XP093133328 * |
| JUNLING WANG ET AL: "Preparation and pharmaceutical/pharmacodynamic evaluation of topical brucine-loaded liposomal hydrogel", JOURNAL OF MATERIALS SCIENCE: MATERIALS IN MEDICINE, KLUWER ACADEMIC PUBLISHERS, BO, vol. 20, no. 10, 21 May 2009 (2009-05-21), pages 2075 - 2084, XP019750145, ISSN: 1573-4838, DOI: 10.1007/S10856-009-3773-6 * |
| See also references of WO2021023099A1 * |
| VALENTA C ET AL: "The use of polymers for dermal and transdermal delivery", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, NL, vol. 58, no. 2, 1 September 2004 (2004-09-01), pages 279 - 289, XP004526312, ISSN: 0939-6411, DOI: 10.1016/J.EJPB.2004.02.017 * |
| WU PING ET AL: "A Novel Brucine Gel Transdermal Delivery System Designed for Anti-Inflammatory and Analgesic Activities", INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 18, no. 4, 3 April 2017 (2017-04-03), pages 757, XP055780285, DOI: 10.3390/ijms18040757 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4008309A1 (en) | 2022-06-08 |
| CN112386565A (en) | 2021-02-23 |
| KR20220042147A (en) | 2022-04-04 |
| CN112386565B (en) | 2024-09-13 |
| US20220313683A1 (en) | 2022-10-06 |
| JP2022542304A (en) | 2022-09-30 |
| WO2021023099A1 (en) | 2021-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3976070A4 (en) | SHAPED ORGANOID COMPOSITIONS AND PROCESSES FOR THEIR PRODUCTION | |
| EP3894428A4 (en) | AFFINITY MEMBRANE AND PROCESS OF PRODUCTION | |
| EP4008309A4 (en) | BRUCIN GEL FORMULATION AND PROCESS OF PRODUCTION | |
| EP4004286A4 (en) | SHAPED FIBER PRODUCT AND METHOD OF PRODUCTION THEREOF | |
| EP3568027A4 (en) | PROCESS FOR THE MANUFACTURE OF NUT FLOURS AND FORMULATIONS FOR ORAL IMMUNOTHERAPY | |
| EP3786121A4 (en) | ANTIBACTERIAL GLASS COMPOSITION AND PROCESS OF PRODUCTION | |
| EP3913003A4 (en) | RGD COMPOSITION WITH CUBIC CYCLODEXTRING STRUCTURE AND METHOD OF PRODUCTION | |
| EP3996683C0 (en) | IMPROVED MRNA-LOADED LIPID DNANOPARTICLES AND METHODS FOR THEIR PRODUCTION | |
| EP4053075A4 (en) | CARBON QUANTUMPOINT COMPOSITION AND PROCESS FOR THEIR PRODUCTION | |
| EP3873451A4 (en) | CANNABINOID ANALOGUES AND METHODS OF PRODUCTION | |
| DE112019002225A5 (en) | Flat gasket and process for its manufacture | |
| EP4072574A4 (en) | THERAPEUTIC CELL COMPOSITIONS AND METHODS OF MAKING AND USES THEREOF | |
| EP3960868A4 (en) | POLYHYDROXYALIC ACID AND PROCESS FOR THE PREPARATION THEREOF | |
| EP3818839A4 (en) | TRIPLE CAPSULE AND DEVICE AND PROCESS FOR THEIR MANUFACTURE | |
| EP3927372A4 (en) | OPTIMIZED VACCINE COMPOSITIONS AND METHODS OF PRODUCTION | |
| EP3731641A4 (en) | DOUGH COMPOSITION AND METHOD FOR MANUFACTURING IT | |
| EP3989968A4 (en) | ORAL FORMULATIONS OF EDARAVON AND PROCESSES FOR THEIR PREPARATION | |
| EP3941700A4 (en) | SYSTEM AND PROCESS FOR MANUFACTURE OF HEMP PRODUCTS | |
| EP3983280A4 (en) | CAR BODY AND PROCESS OF PRODUCTION | |
| EP3815549A4 (en) | FROZEN GYOZA AND PROCESS FOR ITS PRODUCTION | |
| EP3813148A4 (en) | COMPOSITE MEMBRANE AND METHOD OF PRODUCTION | |
| EP3750506C0 (en) | DENTAL PROSTHETIC SYSTEM AND METHOD OF PRODUCTION THEREOF | |
| EP3922435A4 (en) | COMPOSITION, EXTENDED BODY AND METHOD OF PRODUCTION | |
| EP3846934A4 (en) | SUPERABSORBENT ALL-CELLULOUS HYDROGELE AND PROCESS FOR THEIR MANUFACTURE | |
| EP3785721A4 (en) | STEM CELL FILTRATE FORMULATION AND METHOD OF MANUFACTURE THEREOF |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20220214 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20230725 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 29/00 20060101ALI20230719BHEP Ipc: A61P 19/02 20060101ALI20230719BHEP Ipc: A61K 31/475 20060101ALI20230719BHEP Ipc: A61K 47/10 20170101ALI20230719BHEP Ipc: A61K 47/32 20060101ALI20230719BHEP Ipc: A61K 47/42 20170101ALI20230719BHEP Ipc: A61K 47/36 20060101ALI20230719BHEP Ipc: A61K 47/38 20060101ALI20230719BHEP Ipc: A61K 9/00 20060101ALI20230719BHEP Ipc: A61K 9/06 20060101AFI20230719BHEP |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20251027 |